Mechanism of action of methotrexate in rheumatoid arthritis and the search for biomarkers
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mechanism of action of methotrexate in rheumatoid arthritis and the search for biomarkers
Authors
Keywords
-
Journal
Nature Reviews Rheumatology
Volume 12, Issue 12, Pages 731-742
Publisher
Springer Nature
Online
2016-10-27
DOI
10.1038/nrrheum.2016.175
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis
- (2016) Glen S Hazlewood et al. BMJ-British Medical Journal
- Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis
- (2016) Glen S Hazlewood et al. BMJ-British Medical Journal
- Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis
- (2015) Raphael Sanches Peres et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical Utility of Random Anti-Tumor Necrosis Factor Drug-Level Testing and Measurement of Antidrug Antibodies on the Long-Term Treatment Response in Rheumatoid Arthritis
- (2015) Meghna Jani et al. Arthritis & Rheumatology
- A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trial
- (2014) J L Nam et al. ANNALS OF THE RHEUMATIC DISEASES
- Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administration
- (2014) Michael H Schiff et al. ANNALS OF THE RHEUMATIC DISEASES
- Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period
- (2014) Paul Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Adenosine Regulates the Proinflammatory Signaling Function of Thrombin in Endothelial Cells
- (2014) Seyed Mahdi Hassanian et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Genome-wide analysis of methotrexate pharmacogenomics in rheumatoid arthritis shows multiple novel risk variants and leads for TYMS regulation
- (2014) Sabyasachi Senapati et al. Pharmacogenetics and Genomics
- MTHFR functional genetic variation and methotrexate treatment response in rheumatoid arthritis: a meta-analysis
- (2014) Michael D Morgan et al. PHARMACOGENOMICS
- Methotrexate-mediated inhibition of nuclear factor κB activation by distinct pathways in T cells and fibroblast-like synoviocytes
- (2014) Charles F. Spurlock et al. RHEUMATOLOGY
- Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in juvenile idiopathic arthritis patients
- (2013) Maja Bulatović Ćalasan et al. ANNALS OF THE RHEUMATIC DISEASES
- Adalimumab, a human anti-TNF monoclonal antibody, outcome study for the prevention of joint damage in Japanese patients with early rheumatoid arthritis: the HOPEFUL 1 study
- (2013) Tsutomu Takeuchi et al. ANNALS OF THE RHEUMATIC DISEASES
- Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial
- (2013) Kim Hørslev-Petersen et al. ANNALS OF THE RHEUMATIC DISEASES
- Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in patients with rheumatoid arthritis
- (2013) Maurits C F J de Rotte et al. ANNALS OF THE RHEUMATIC DISEASES
- Validation of the Methotrexate-First Strategy in Patients With Early, Poor-Prognosis Rheumatoid Arthritis: Results From a Two-Year Randomized, Double-Blind Trial
- (2013) James R. O'Dell et al. ARTHRITIS AND RHEUMATISM
- Methotrexate Normalizes Up-Regulated Folate Pathway Genes in Rheumatoid Arthritis
- (2013) Marjolein Blits et al. ARTHRITIS AND RHEUMATISM
- Comparison of intracellular methotrexate kinetics in red blood cells with the kinetics in other cell types
- (2013) Julia Korell et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis
- (2013) Noriko Komatsu et al. NATURE MEDICINE
- Genetic variants associated with methotrexate efficacy and toxicity in early rheumatoid arthritis: results from the treatment of early aggressive rheumatoid arthritis trial
- (2013) S Aslibekyan et al. PHARMACOGENOMICS JOURNAL
- A2A Adenosine Receptors Are Differentially Modulated by Pharmacological Treatments in Rheumatoid Arthritis Patients and Their Stimulation Ameliorates Adjuvant-Induced Arthritis in Rats
- (2013) Fabrizio Vincenzi et al. PLoS One
- Golimumab, a Human Anti-Tumor Necrosis Factor Monoclonal Antibody, Injected Subcutaneously Every 4 Weeks in Patients With Active Rheumatoid Arthritis Who Had Never Taken Methotrexate: 1-Year and 2-Year Clinical, Radiologic, and Physical Function Findings
- (2013) Paul Emery et al. ARTHRITIS CARE & RESEARCH
- RFC180G>A Is a Genetic Determinant of Methotrexate Efficacy in Rheumatoid Arthritis: A Human Genome Epidemiologic Review and Meta-Analysis of Observational Studies
- (2013) Tabitha N. Kung et al. Arthritis & Rheumatology
- Regulation of Inflammation by Adenosine
- (2013) György Haskó et al. Frontiers in Immunology
- Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naïve patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study
- (2012) Jacqueline Detert et al. ANNALS OF THE RHEUMATIC DISEASES
- Methotrexate polyglutamation in relation to infliximab pharmacokinetics in rheumatoid arthritis
- (2012) Thierry Dervieux et al. ANNALS OF THE RHEUMATIC DISEASES
- Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial
- (2012) P H de Jong et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study
- (2012) Arthur Kavanaugh et al. ANNALS OF THE RHEUMATIC DISEASES
- The human proton-coupled folate transporter
- (2012) Sita Kugel Desmoulin et al. CANCER BIOLOGY & THERAPY
- The Antifolates
- (2012) Michele Visentin et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Clinical pharmacogenetic model to predict response of MTX monotherapy in patients with established rheumatoid arthritis after DMARD failure
- (2012) Jaap Fransen et al. PHARMACOGENOMICS
- Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients
- (2012) S A Owen et al. PHARMACOGENOMICS JOURNAL
- FcγRIIIa Expression on Monocytes in Rheumatoid Arthritis: Role in Immune-Complex Stimulated TNF Production and Non-Response to Methotrexate Therapy
- (2012) Dawn L. Cooper et al. PLoS One
- Adenosine receptor expression in rheumatoid synovium: a basis for methotrexate action
- (2012) Lisa K Stamp et al. ARTHRITIS RESEARCH & THERAPY
- Increased sensitivity to apoptosis induced by methotrexate is mediated by JNK
- (2011) Charles F. Spurlock et al. ARTHRITIS AND RHEUMATISM
- Increased recycling of polyamines is associated with global DNA hypomethylation in rheumatoid arthritis synovial fibroblasts
- (2011) Emmanuel Karouzakis et al. ARTHRITIS AND RHEUMATISM
- T-cell specific defect in expression of the NTPDase CD39 as a biomarker for lupus
- (2011) Matthew J. Loza et al. CELLULAR IMMUNOLOGY
- Dihydrofolate reductase protects endothelial nitric oxide synthase from uncoupling in tetrahydrobiopterin deficiency
- (2011) Mark J. Crabtree et al. FREE RADICAL BIOLOGY AND MEDICINE
- Effects of Changing from Oral to Subcutaneous Methotrexate on Red Blood Cell Methotrexate Polyglutamate Concentrations and Disease Activity in Patients with Rheumatoid Arthritis
- (2011) LISA K. STAMP et al. JOURNAL OF RHEUMATOLOGY
- Adenosine abolishes MTX-induced suppression of osteoclastogenesis and inflammatory bone destruction in adjuvant-induced arthritis
- (2011) Junpei Teramachi et al. LABORATORY INVESTIGATION
- Patterns of interaction between genetic and nongenetic attributes and methotrexate efficacy in rheumatoid arthritis
- (2011) Thierry Dervieux et al. Pharmacogenetics and Genomics
- International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors--An Update
- (2011) B. B. Fredholm et al. PHARMACOLOGICAL REVIEWS
- Serum adenosine deaminase may predict disease activity in rheumatoid arthritis
- (2011) Batool Zamani et al. RHEUMATOLOGY INTERNATIONAL
- Treatment of Early Rheumatoid Arthritis: Concepts in Management
- (2011) Boulos Haraoui et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release
- (2011) Katia Varani et al. ARTHRITIS RESEARCH & THERAPY
- Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial
- (2010) P. P. Tak et al. ANNALS OF THE RHEUMATIC DISEASES
- Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy
- (2010) Lisa K. Stamp et al. ARTHRITIS AND RHEUMATISM
- The effect of genotype on methotrexate polyglutamate variability in juvenile idiopathic arthritis and association with drug response
- (2010) Mara L. Becker et al. ARTHRITIS AND RHEUMATISM
- Red blood cell methotrexate polyglutamates emerge as a function of dosage intensity and route of administration during pulse methotrexate therapy in rheumatoid arthritis
- (2010) Thierry Dervieux et al. RHEUMATOLOGY
- Adenosine 5'-triphosphate infusions reduced disease activity and inflammation in a patient with active rheumatoid arthritis
- (2010) M. J. L. Bours et al. RHEUMATOLOGY
- Normalization of A2Aand A3adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor α but not methotrexate
- (2009) Katia Varani et al. ARTHRITIS AND RHEUMATISM
- Gene expression profiling of leukemia T-cells resistant to methotrexate and 7-hydroxymethotrexate reveals alterations that preserve intracellular levels of folate and nucleotide biosynthesis
- (2009) Alan Kambiz Fotoohi et al. BIOCHEMICAL PHARMACOLOGY
- CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis
- (2009) J. M. Fletcher et al. JOURNAL OF IMMUNOLOGY
- Purine biosynthetic pathway genes and methotrexate response in rheumatoid arthritis patients among north Indians
- (2009) Shruti Sharma et al. Pharmacogenetics and Genomics
- Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial
- (2009) M. Soubrier et al. RHEUMATOLOGY
- Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature
- (2008) K Visser et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research
- (2008) C Salliot et al. ANNALS OF THE RHEUMATIC DISEASES
- Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
- (2008) György Haskó et al. NATURE REVIEWS DRUG DISCOVERY
- Interaction of genes from influx-metabolism-efflux pathway and their influence on methotrexate efficacy in rheumatoid arthritis patients among Indians
- (2008) Shruti Sharma et al. Pharmacogenetics and Genomics
- Cyclic adenosine 5′-monophosphate in synovial fluid of rheumatoid arthritis and osteoarthritis patients
- (2008) Jadranka Morovic-Vergles et al. RHEUMATOLOGY INTERNATIONAL
- Leflunomide and methotrexate reduce levels of activated matrix metalloproteinases in complexes with 2 macroglobulin in serum of rheumatoid arthritis patients
- (2007) I Tchetverikov et al. ANNALS OF THE RHEUMATIC DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started